Dagandan, Baby Girl -.
HRN: 23-59-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
08/26/2023
09/02/2023
IV
15mg
Q24
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiricEmpirical De-escalation Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes